MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Children of married parents less likely to be obese Full Text EurekAlert!, May 23, 2013
2 Women who smoke during pregnancy increase the risk of both obesity and gestational diabetes in their daughters Full Text ScienceDaily, May 23, 2013
3 Novel approach to regulating blood sugar levels in the body Full Text ScienceDaily, May 23, 2013
4 NIH funds studies to improve type 2 and prediabetes treatment Full Text NIH News, May 23, 2013
5 Underactive Thyroid and Heart Failure a Bad Combination: Study Full Text HealthDay, May 23, 2013
6 Fish Oil Pills Might Cut Diabetes Risk, Researchers Say Full Text HealthDay, May 23, 2013
7 Doctors and hospitals’ use of health IT more than doubles since 2012 HHS News Releases, May 23, 2013
8 Better care not always better business Full Text Healthcare IT News, May 22, 2013
9 9 'Cs' lead to accountable care Full Text Healthcare IT News, May 22, 2013
10 Genetic risk for obesity found in many Mexican young adults Full Text EurekAlert!, May 22, 2013
11 Anabolic steroids may affect future mental health Full Text ScienceDaily, May 22, 2013
12 Child maltreatment increases risk of adult obesity Full Text ScienceDaily, May 22, 2013
13 Discovery of a novel medicine for the treatment of chronic wounds Full Text ScienceDaily, May 22, 2013
14 Immune protein could stop diabetes in its tracks, discovery suggests Full Text ScienceDaily, May 22, 2013
15 People choose larger portions of ‘healthy' foods Full Text Reuters Health News, May 22, 2013
16 A molecular explanation for age-related fertility decline in women Full Text NIH News, May 22, 2013
17 Marijuana: The Next Diabetes Drug? Full Text Time, May 22, 2013
18 Depression May Raise Low Blood Sugar Risk in Diabetics Full Text HealthDay, May 22, 2013
19 URAC standards put to the test Full Text Healthcare IT News, May 21, 2013
20 Breakup of physician, drug company relationship could improve health care, cut cost Full Text EurekAlert!, May 21, 2013
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summaryIndexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close